High risk of systemic lupus erythematosus development in patients with ITP: antiphospholipid syndrome is also a concern
| Autor: | Bahar Artim-Esen, Murat Inanc, Reyhan Diz-Kucukkaya |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Pediatrics medicine.medical_specialty Immunology Population medicine.disease_cause General Biochemistry Genetics and Molecular Biology Autoimmunity 03 medical and health sciences 0302 clinical medicine Immune system Rheumatology immune system diseases Antiphospholipid syndrome Epidemiology medicine Immunology and Allergy Humans Lupus Erythematosus Systemic education 030203 arthritis & rheumatology education.field_of_study business.industry Undifferentiated connective tissue disease medicine.disease Antiphospholipid Syndrome Thrombocytopenic purpura 030104 developmental biology Antibodies Antiphospholipid business Cohort study |
| Zdroj: | Annals of the rheumatic diseases. 81(7) |
| ISSN: | 1468-2060 |
| Popis: | Zhu et al in their elegant population-based cohort study investigated the development of systemic lupus erythematosus (SLE) in patients with idiopathic (immune) thrombocytopenic purpura (ITP) and demonstrated the significantly higher risk compared with the control population.1 They rightfully used sensitivity analysis and treatment data to improve the accuracy of clinical diagnosis. Despite this effort, the difficulty remains to compare epidemiological studies using self-reported diagnosis, health records or using classification criteria.2 In clinical practice, lack of a generally acknowledged diagnostic criteria might lead to SLE diagnosis of cases like undifferentiated connective tissue disease that … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|